Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency

Cell Rep Med. 2022 Oct 18;3(10):100766. doi: 10.1016/j.xcrm.2022.100766. Epub 2022 Oct 4.

Abstract

Programmed cell death 1 (PD1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4) suppress CD4+ T cell activation and may promote latent HIV infection. By performing leukapheresis (n = 21) and lymph node biopsies (n = 8) in people with HIV on antiretroviral therapy (ART) and sorting memory CD4+ T cells into subsets based on PD1/CTLA4 expression, we investigate the role of PD1 and CTLA 4 in HIV persistence. We show that double-positive (PD1+CTLA4+) cells in blood contain more HIV DNA compared with double-negative (PD1-CTLA4-) cells but still have a lower proportion of cells producing multiply spliced HIV RNA after stimulation as well as reduced upregulation of T cell activation and proliferation markers. Transcriptomics analyses identify differential expression of key genes regulating T cell activation and proliferation with MAF, KLRB1, and TIGIT being upregulated in double-positive compared with double-negative cells, whereas FOS is downregulated. We conclude that, in addition to being enriched for HIV DNA, double-positive cells are characterized by negative signaling and a reduced capacity to respond to stimulation, favoring HIV latency.

Keywords: CTLA4; HIV; HIV cure; HIV latency; HIV persistence; HIV reservoirs; PD1; T cell exhaustion; immune checkpoints.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • CD4-Positive T-Lymphocytes
  • CTLA-4 Antigen / genetics
  • HIV Infections*
  • Humans
  • Programmed Cell Death 1 Receptor / metabolism
  • RNA
  • Receptors, Immunologic
  • T-Lymphocytes

Substances

  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Receptors, Immunologic
  • RNA
  • Programmed Cell Death 1 Receptor